SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

(NASDAQ:SLP), NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Simulations Plus, Inc. (NASDAQ: SLP) resulting from allegations that Simulations Plus may have issued materially misleading business information to the investing public. SO WHAT: If […]

SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights

SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights GlobeNewswire September 05, 2025 NEW YORK, Sept. 04, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on

Investor Alert: Deadline Approaching to Join Replimune Group, Inc. (REPL) Class Action – Contact Levi & Korsinsky

NEW YORK CITY, NY / ACCESS Newswire / September 4, 2025 / If you suffered a loss on your Replimune Group, Inc. (NASDAQ:REPL) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/replimune-group-inc-lawsuit-submission-form?prid=165420&wire=1&utm_campaign=25 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com

ROSEN, HIGHLY REGARDED INVESTOR RIGHTS COUNSEL, Encourages Novo Nordisk A/S Investors to Secure Counsel Before Important Deadline in Securities Class Action – NVO

NEW YORK CITY, NY / ACCESS Newswire / September 4, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE:NVO) between May 7, 2025 and July 28, 2025, both dates inclusive (the "Class Period"), of the important September 30, 2025 lead plaintiff deadline. SO

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Nutex Health Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NUTX

NEW YORK CITY, NY / ACCESS Newswire / September 4, 2025 / WHY: New York, N.Y., September 4, 2025. Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Nutex Health Inc. (NASDAQ:NUTX) between August 8, 2024 and August 14, 2025, both dates inclusive (the "Class Period"), of the important October

DOW SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Dow Inc. – DOW

NEW YORK CITY AND NEW ORLEANS / ACCESS Newswire / September 4, 2025 / Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until October 28, 2025 to file lead plaintiff applications in a securities class action lawsuit against Dow Inc.

RE+ 2025: Ampace to Showcase Breakthrough Innovations and Reinforce Commitment to Safety

September 9 to 11,Ampace will return to RE+ 2025 with a defining milestone: theindustry's first mass-produced semi-solid battery cells, set to mark a new era of safer, denser,and more efficient energy storage-from data centers to homes. https://mma.prnewswire.com/media/2765239/image.jpg This year's showcase reflects Ampace's steady progression from pioneering R&D to real-worldimpact. With over 20 years of expertise

Class Action Filed Against RxSight, Inc. (RXST) Over Securities Violations – Contact Levi & Korsinsky Today

NEW YORK, NY / ACCESS Newswire / September 4, 2025 / If you suffered a loss on your RxSight, Inc. (NASDAQ:RXST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=165419&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call

REPL DEADLINE: ROSEN, LEADING INVESTOR COUNSEL, Encourages Replimune Group, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – REPL

NEW YORK, NY / ACCESS Newswire / September 4, 2025 / WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Replimune Group, Inc. (NASDAQ:REPL) between November 22, 2024 and July 21, 2025, both dates inclusive (the "Class Period"), of the important September 22, 2025 lead plaintiff deadline in the

Scroll to Top